Cost effectiveness of duloxetine in the treatment of diabetic peripheral neuropathic pain in the UK

Author： Beard S. M. McCrink L. Le T. K. Garcia-Cebrian A. Monz B. Malik R. A.

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.24, Iss.2, 2008-02, pp. : 385-399

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety and Efficacy of Duloxetine in the Treatment of Diabetic Peripheral Neuropathic Pain in Older Patients

Current Drug Safety, Vol. 4, Iss. 1, 2009-01 ,pp. : 22-29

Bentham Science Publishers

Access to resources Recommend Favorite

Duloxetine treatment and glycemic controls in patients with diagnoses other than diabetic peripheral neuropathic pain: a meta-analysis

By Crucitti Antonio Zhang Qi Nilsson Mary Brecht Stephan Yang Charles R. Wernicke Joachim

Current Medical Research and Opinion, Vol. 26, Iss. 11, 2010-11 ,pp. : 2579-2588

Informa Healthcare

Access to resources Recommend Favorite

Treatment of patients with diabetic peripheral neuropathic pain in China: a double‐blind randomised trial of duloxetine vs. placebo

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. 9, 2015-09 ,pp. : 957-966

John Wiley & Sons Inc

Access to resources Recommend Favorite

Suboptimal Treatment of Diabetic Peripheral Neuropathic Pain in the United States

PAIN MEDICINE, Vol. 16, Iss. 11, 2015-11 ,pp. : 2075-2083

John Wiley & Sons Inc

Access to resources Recommend Favorite

Changes in opioid use and healthcare costs among U.S. patients with diabetic peripheral neuropathic pain treated with duloxetine compared with other therapies

By Zhao Y. Wu N. Chen S. Boulanger L. Police R.L. Fraser K.

Current Medical Research and Opinion, Vol. 26, Iss. 9, 2010-09 ,pp. : 2147-2156

Informa Healthcare

Access to resources Recommend Favorite